Wallentin Lars, Zethelius Björn, Berglund Lars, Eggers Kai M, Lind Lars, Lindahl Bertil, Wollert Kai C, Siegbahn Agneta
Uppsala Clinical Research Center (UCR) and Department of Medical Sciences, Uppsala University, Uppsala, Sweden.
PLoS One. 2013 Dec 2;8(12):e78797. doi: 10.1371/journal.pone.0078797. eCollection 2013.
The objective was to evaluate the hypothesis that growth-differentiation factor 15 (GDF-15) is an independent marker of the long-term risk for both cardiovascular disease and cancer morbidity beyond clinical and biochemical risk factors. Plasma obtained at age 71 was available from 940 subjects in the Uppsala Longitudinal Study of Adult Men (ULSAM) cohort. Complete mortality and morbidity data were obtained from public registries. At baseline there were independent associations between GDF-15 and current smoking, diabetes mellitus, biomarkers of cardiac (high-sensitivity troponin-T, NT-proBNP) and renal dysfunction (cystatin-C) and inflammatory activity (C-reactive protein), and previous cardiovascular disease (CVD). During 10 years follow-up there occurred 265 and 131 deaths, 115 and 46 cardiovascular deaths, and 185 and 86 events with coronary heart disease mortality or morbidity in the respective total cohort (n=940) and non-CVD (n=561) cohort. After adjustment for conventional cardiovascular risk factors, one SD increase in log GDF-15 were, in the respective total and non-CVD populations, associated with 48% (95%CI 26 to 73%, p<0.001) and 67% (95%CI 28 to 217%, p<0.001) incremental risk of cardiovascular mortality, 48% (95%CI 33 to 67%, p<0.001) and 61% (95%CI 38 to 89%, p<0.001) of total mortality and 36% (95%CI 19 to 56%, p<0.001) and 44% (95%CI 17 to 76%, p<0.001) of coronary heart disease morbidity and mortality. The corresponding incremental increase for cancer mortality in the respective total and non-cancer disease (n=882) population was 46% (95%CI 21 to 77%, p<0.001) and 38% (95%CI 12 to 70%, p<0.001) and for cancer morbidity and mortality in patients without previous cancer disease 30% (95%CI 12 to 51%, p<0.001). In conclusion, in elderly men, GDF-15 improves prognostication of both cardiovascular, cancer mortality and morbidity beyond established risk factors and biomarkers of cardiac, renal dysfunction and inflammation.
目的是评估生长分化因子15(GDF - 15)是心血管疾病和癌症发病长期风险的独立标志物这一假设,该风险独立于临床和生化风险因素。在乌普萨拉成年男性纵向研究(ULSAM)队列中,940名受试者提供了71岁时采集的血浆。完整的死亡率和发病率数据来自公共登记处。在基线时,GDF - 15与当前吸烟、糖尿病、心脏生物标志物(高敏肌钙蛋白 - T、NT - 脑钠肽)、肾功能不全(胱抑素 - C)、炎症活动(C反应蛋白)以及既往心血管疾病(CVD)之间存在独立关联。在10年随访期间,在各自的总队列(n = 940)和非心血管疾病队列(n = 561)中,分别发生了265例和131例死亡、115例和46例心血管死亡以及185例和86例冠心病死亡或发病事件。在对传统心血管危险因素进行调整后,在各自的总人群和非心血管疾病人群中,log GDF - 15每增加一个标准差,心血管死亡率的增量风险分别为48%(95%CI 26%至73%,p < 0.001)和67%(95%CI 28%至217%,p < 0.001),总死亡率分别为48%(95%CI 33%至67%,p < 0.001)和61%(95%CI 38%至89%,p < 0.001),冠心病发病和死亡率分别为36%(95%CI 19%至56%,p < 0.001)和44%(95%CI 17%至76%,p < 0.001)。在各自的总人群和非癌症疾病人群(n = 882)中,癌症死亡率的相应增量分别为46%(95%CI 21%至77%,p < 0.001)和38%(95%CI 12%至70%,p < 0.001),在无既往癌症疾病的患者中,癌症发病和死亡率为30%(95%CI 12%至51%,p < 0.001)。总之,在老年男性中,GDF - 15在既定的风险因素以及心脏、肾功能不全和炎症的生物标志物之外,改善了心血管疾病、癌症死亡率和发病率以及癌症发病和死亡率的预后。